Directory of funded grants

Filter by

721 results found

The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): Building a Research, Practice and Policy Foundation

  • Grant Type

    Team grants

  • Area of research

    Mental Health

  • Disease Area

    Mental illness

  • Competition

    2024 CCS Breakthrough Team Grants - Transforming the future of metastatic cancer

  • Province

    Alberta

  • Start Date

    2025

  • Total Grant Amount

    $5,478,935

  • Health Canada Contribution

    $413,500

Project Overview

A new national initiative funded by the Canadian Cancer Society, the Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT), is bringing together researchers, clinicians, policymakers, and people living with advanced cancer to explore the potential of psychedelic-assisted therapy as a transformative approach to cancer care. People with advanced cancer often experience…

Transforming Palliative Care for People Living with Advanced Cancer: Developing a National Research Platform

  • Area of research

    Mental Health

  • Disease Area

    Brain CancerMental illness

  • Competition

    2024 CCS Breakthrough Team Grants - Transforming the future of metastatic cancer

  • Province

    Ontario

  • Start Date

    2025

  • Total Grant Amount

    $5,899,008

  • Health Canada Contribution

    $562,122

Project Overview

Palliative care (PC) is an area of medicine that focuses on symptom control and quality of life of patients with life-limiting illnesses and their families. PC can be provided at any point in the cancer experience, even alongside cancer treatments. PC can improve symptoms and quality of life, but the…

Novel Repetitive Transcranial Magnetic Stimulation Paradigm to Reduce Cortical Hyperexcitability in Patients with ALS

  • Area of research

    Neurodegeneration

  • Disease Area

    ALS

  • Competition

    ALS Canada - Brain Canada Discovery Grants

  • Province

    Ontario

  • Start Date

    2025

  • Total Grant Amount

    $125,000

  • Health Canada Contribution

    $62,500

Project Overview

ALS is a devastating neurological disease characterized by the progressive degeneration of motor neurons leading to paralysis and death. Although the exact cause of ALS remains unknown in the majority of patients, abnormalities in the motor cortex of the brain can be detected early in the disease and may be…

A multi-methods multi-site study of end-of-life care in individuals with ALS: goal concordance and caregiver perceptions

  • Area of research

    Neurodegeneration

  • Disease Area

    ALS

  • Competition

    ALS Canada - Brain Canada Discovery Grants

  • Province

    Ontario

  • Start Date

    2025

  • Total Grant Amount

    $125,000

  • Health Canada Contribution

    $62,500

Project Overview

Amyotrophic lateral sclerosis (ALS) is a terminal disease of nerves and muscles. From the time of symptom onset, people with ALS live about 3-5 years. Death results in significant grief in their caregivers. Previous research has shown where people with ALS are dying, but none have shown where they want…

Exploring a therapeutic approach to promote neuronal function for ALS

  • Area of research

    Neurodegeneration

  • Disease Area

    ALS

  • Competition

    ALS Canada - Brain Canada Discovery Grants

  • Province

    Ontario

  • Start Date

    2025

  • Total Grant Amount

    $125,000

  • Health Canada Contribution

    $62,500

Project Overview

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two devastating neurodegenerative diseases which have overlap in pathological features and the genetic basis. We recently discovered that treating mouse neurons Analysis of neurons isolated from mice which carry a genetic alteration associated with human ALS/FTD, revealed a variety of defects…